Skip to main content
Home

Search form

  • ABOUT US
    • ECFS Society Details
      • Society Information
      • Applications for Support
    • ECFS Membership
      • Membership Subscription
      • Membership Demographics
    • Other Information
      • Latest News
      • Job Opportunities
      • Grants and Programmes
      • Links
  • RESEARCH
    • ECFS Projects
      • ECFS Clinical Trials Network
      • ECFS Patient Registry
    • ECFS Working Groups
      • Diagnostic Network
      • Exercise
      • Neonatal Screening
      • Fungal Pathogens
      • Pulmonary Exacerbation
    • Special Projects
      • ECFS / CF Europe Post-Doctoral Research Fellowship
      • CFQ-R questionnaire and CF candidates for lung transplant
      • EU funded projects
      • MucoFong International Project
      • Complete CFTR gene mutation analysis in European patients with Cystic Fibrosis
    • Past Working Groups
      • Cystic Fibrosis Molecular and Cell Biology and Physiology Basic Science
      • ECFS Gene Modifier Working Group
      • ECFS Non Tuberculous Mycobacteria Working Group
  • CARE
    • ECFS Standards Of Care
    • ECFS Working Groups
      • Exercise
      • Diagnostic Network
      • Neonatal Screening
      • Mental Health
      • Fungal Pathogens
      • Pulmonary Exacerbation
      • Telehealth
      • ECFS Intestinal Organoid Working Group
      • Intestinal Organoid Working Group
    • Allied Health Professionals
      • ECFS Nursing Special interest Group
      • European CF Pharmacy Group
      • European Cystic Fibrosis Nutrition Group
      • European Psychosocial Special Interest Group
      • ECFS Physiotherapy Special Interest International Group
  • EDUCATION
  • CONFERENCES & EVENTS
    • European Cystic Fibrosis Conference
    • ECFS Basic Science Conference
    • Related events
    • Past ECFS conferences
  • PUBLICATIONS
    • About Publications
      • The Journal of Cystic Fibrosis
      • ECFS Newsletter
      • ECFS Book
      • ERS Monograph
    • Resources
      • Search All Resources
      • CF Research News
      • Consensus Reports
      • ECFS Guidelines
      • Free Access Articles
      • CF Literature
  • MEMBERSHIP
  • LOG IN

Other Guidelines

New perspectives on physical exercise training in adults and children with cystic fibrosis

  • Read more about New perspectives on physical exercise training in adults and children with cystic fibrosis

Review of abnormal Stomach and Intestinal Movement in Cystic Fibrosis

  • Read more about Review of abnormal Stomach and Intestinal Movement in Cystic Fibrosis

A study of the drug riociguat as a possible treatment for people with cystic fibrosis

  • Read more about A study of the drug riociguat as a possible treatment for people with cystic fibrosis

Do cystic fibrosis patients have an abnormal innate immune response to pathogens?

  • Read more about Do cystic fibrosis patients have an abnormal innate immune response to pathogens?

Early signs of Cystic Fibrosis Related Diabetes (CFRD) and low amount of the neuropeptide VIP in ΔF508-CF mice.

  • Read more about Early signs of Cystic Fibrosis Related Diabetes (CFRD) and low amount of the neuropeptide VIP in ΔF508-CF mice.

“Coping and Learning to Manage Stress with CF” a Telehealth Pilot Intervention

  • Read more about “Coping and Learning to Manage Stress with CF” a Telehealth Pilot Intervention

The influence of cystic fibrosis on work ability of affected patients

  • Read more about The influence of cystic fibrosis on work ability of affected patients

Clofazimine use for treatment of mycobacteria in children with and without cystic fibrosis

  • Read more about Clofazimine use for treatment of mycobacteria in children with and without cystic fibrosis

Stopping exposure to smoke improves breathing and nutritional outcomes in children and adolescents with cystic fibrosis

  • Read more about Stopping exposure to smoke improves breathing and nutritional outcomes in children and adolescents with cystic fibrosis

Use of elexacaftor/tezacaftor/ivacaftor in liver transplant patients with cystic fibrosis

  • Read more about Use of elexacaftor/tezacaftor/ivacaftor in liver transplant patients with cystic fibrosis
  • first
  • previous
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • …
  • next
  • last
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2026. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)